Publications
- MxA mRNA decrease preceding NAb detection in IFN beta-treated MS patients2017 | First Faculty of Medicine, Second Faculty of Medicine
- Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFN beta2017 | First Faculty of Medicine, Second Faculty of Medicine
- Understanding the positive benefit: risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program2017 | First Faculty of Medicine, Second Faculty of Medicine
- Myxovirus resistance protein A in interferon-β therapy in patients with multiple sclerosis and treatment effectiveness monitoring algorithm2016 | First Faculty of Medicine, Second Faculty of Medicine
- Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use2015 | First Faculty of Medicine
- Panikulitida a lipoatrofie po podkožním podání interferonu beta u pacientů s roztroušenou sklerózouPublication without faculty affiliation
- Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?2024 | First Faculty of Medicine
- Multiple Sclerosis and Microbiome2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Long-term management of oral cladribine treatment in multiple sclerosis2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
Loading network view...